Biodegradable Microspheres for Transarterial Chemoembolization in Malignant Liver Disease.
Medicina (Kaunas)
; 60(4)2024 Apr 22.
Article
em En
| MEDLINE
| ID: mdl-38674324
ABSTRACT
Transarterial chemoembolization (TACE) has revolutionized the treatment landscape for malignant liver disease, offering localized therapy with reduced systemic toxicity. This manuscript delves into the use of degradable microspheres (DMS) in TACE, exploring its potential advantages and clinical applications. DMS-TACE emerges as a promising strategy, offering temporary vessel occlusion and optimized drug delivery. The manuscript reviews the existing literature on DMS-TACE, emphasizing its tolerability, toxicity, and efficacy. Notably, DMS-TACE demonstrates versatility in patient selection, being suitable for both intermediate and advanced stages. The unique properties of DMS provide advantages over traditional embolic agents. The manuscript discusses the DMS-TACE procedure, adverse events, and tumor response rates in HCC, ICC, and metastases.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Quimioembolização Terapêutica
/
Neoplasias Hepáticas
/
Microesferas
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Grécia